Notch signaling in advanced prostate cancer
Himisha Beltran, Associate Professor of Medicine at Dana Farber Cancer Institute, shared a post on X about recent paper by Sheng-Yu Ku et al., commenting:
“Proud to share our lab’s new paper The Journal of Clinical Investigation led by Sheng-Yu Ku Dana-Farber Cancer Institute in collaboration with Good rich Lab and Roswell Park
Notch signaling suppresses neuroendocrine differentiation and alters the immune microenvironment in advanced prostate cancer.”
Journal: Journal of Clinical Investigation
Author: Sheng-Yu Ku, Yanqing Wang, Maria Mica Garcia, Yasutaka Yamada, Kei Mizuno, Mark D. Long, Spencer Rosario, Meenalakshmi Chinnam, Majd Al Assaad, Loredana Puca, Min Jin Kim, Martin K. Bakht, Varadha Balaji Venkadakrishnan, Brian D. Robinson, Andrés M. Acosta, Kristine M. Wadosky, Juan Miguel Mosquera, David W. Goodrich and Himisha Beltran
Source: Himisha Beltran/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023